FREQ Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 lapkr. 2023 @ 22:00):

Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function...

Stats
Šios dienos apimtis	309 164
Vidutinė apimtis	135 075
Rinkos kapitalizacija	10.94M
EPS	$0 ( 2024-03-08 )
Kita pelno data	( $0 ) 2024-05-10
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.158
ATR14	$0.0510 (17.02%)

Insider Trading

Date	Person	Action	Amount	type
2023-11-27	Meyers Rachel	Buy	12 551	Stock Option (Right to Buy)
2023-11-27	Meyers Rachel	Buy	0
2023-11-22	Lucchino David L.	Sell	110	Common Stock
2023-11-22	Lucchino David L.	Sell	230	Common Stock
2023-11-22	Lucchino David L.	Sell	614	Common Stock

INSIDER POWER
96.44
Last 81 transactions
Buy: 3 077 272 \| Sell: 64 406

Tūris Koreliacija

Ilgas: 0.24 (neutral)

Trumpas: -0.40 (neutral)

Signal:(51.699) Neutral

Frequency Therapeutics Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
REVB	0.883
GLPG	0.882
STAF	0.873
GMII	0.873
ZYXI	0.872
SNES	0.871
IMPL	0.867
YQ	0.866
VREX	0.853
TRIT	0.851

10 Labiausiai neigiamai susiję koreliacijos
SHSP	-0.952
MMAC	-0.944
BNFT	-0.922
EXFO	-0.895
GTYH	-0.89
MNTX	-0.887
ANDA	-0.886
COUP	-0.884
FTNT	-0.868
RMRM	-0.867

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Frequency Therapeutics Koreliacija - Valiuta/Žaliavos

-0.41
( neutral )

-0.72
( moderate negative )

-0.30
( neutral )

-0.66
( moderate negative )

-0.80
( moderate negative )

0.20
( neutral )

Frequency Therapeutics Finansinės ataskaitos

Annual	2022
Pajamos:	$0
Bruto pelnas:	$0 (0.00 %)
EPS:	$-2.33

FY	2022
Pajamos:	$0
Bruto pelnas:	$0 (0.00 %)
EPS:	$-2.33

FY	2021
Pajamos:	$14 068.00
Bruto pelnas:	$14 068.00 (100.00 %)
EPS:	$-0.00246

FY	2020
Pajamos:	$36.98M
Bruto pelnas:	$36.98M (100.00 %)
EPS:	$-0.820

Financial Reports:

No articles found.

Frequency Therapeutics

Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candidate is FX-322, which is in Phase IIa clinical trial to treat the underlying cause of sensorineural hearing loss. It is also developing medicines for patients across a range of degenerative conditions, including multiple sclerosis, and diseases of the muscle, gastrointestinal tract, skin, and bone. The company has a license and collaboration agreement with Astellas Pharma Inc. for the development and commercialization of FX-322, as well as collaboration and licensing agreements with Massachusetts Eye and Ear, the Massachusetts Institute of Technology, The Scripps Research Institute, and Cambridge Enterprises Limited. Frequency Therapeutics, Inc. was incorporated in 2014 and is headquartered in Lexington, Massachusetts.